We have developed an AI-generated antibody library platform utilizing a Generative Adversarial Network (GAN) that generates novel sequences which mimic natural human response, as well biasing toward diversity and developability features.
The resulting Humanoid Antibody LibrarySM (HALSM) was successfully screened to obtain a panel of novel, diverse and pharmacologically active human antibodies against SARS-CoV-2.